Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Haller

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancerM J O'Connell, J A Mailliard, M J Kahn, et al.
The New England Journal of Medicine|April 20, 2001
Molecular predictors of survival after adjuvant chemotherapy for colon cancerT Watanabe, T T Wu, P J Catalano, et al.
Annals of Internal Medicine|July 4, 1998
Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology GroupR M Goldberg, T R Fleming, C M Tangen, et al.
Investigational New Drugs|January 19, 2000
A phase II trial of homoharringtonine and caracemide in the treatment of patients with advanced large bowel cancerR S Witte, S Lipsitz, T L Goodman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089T E Le Voyer, E R Sigurdson, A L Hanlon, et al.
Cancer Treatment Reports|October 1, 1987
Actual versus ideal weight in the calculation of surface area: effects on dose of 11 chemotherapy agentsR S Gelman, D C Tormey, R Betensky, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinomaC D Blanke, D G Haller, A B Benson, et al.
Cancer|November 15, 1995
Results of combined modality therapy for patients with anal cancer (E7283). An Eastern Cooperative Oncology Group studyJ A Martenson, S R Lipsitz, M Lefkopoulou, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|February 1, 1993
Phase II multicenter evaluation of prolonged murine monoclonal antibody 17-1A therapy in pancreatic carcinomaL M Weiner, E Harvey, K Padavic-Shaller, et al.
The American Journal of Gastroenterology|September 25, 2001
Long term survival after pancreatic resection for pancreatic adenocarcinomaN A Ahmad, J D Lewis, G G Ginsberg, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancerM J O'Connell, J A Mailliard, M J Kahn, et al.
The New England Journal of Medicine|April 20, 2001
Molecular predictors of survival after adjuvant chemotherapy for colon cancerT Watanabe, T T Wu, P J Catalano, et al.
Annals of Internal Medicine|July 4, 1998
Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology GroupR M Goldberg, T R Fleming, C M Tangen, et al.
Investigational New Drugs|January 19, 2000
A phase II trial of homoharringtonine and caracemide in the treatment of patients with advanced large bowel cancerR S Witte, S Lipsitz, T L Goodman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089T E Le Voyer, E R Sigurdson, A L Hanlon, et al.
Cancer Treatment Reports|October 1, 1987
Actual versus ideal weight in the calculation of surface area: effects on dose of 11 chemotherapy agentsR S Gelman, D C Tormey, R Betensky, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinomaC D Blanke, D G Haller, A B Benson, et al.
Cancer|November 15, 1995
Results of combined modality therapy for patients with anal cancer (E7283). An Eastern Cooperative Oncology Group studyJ A Martenson, S R Lipsitz, M Lefkopoulou, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|February 1, 1993
Phase II multicenter evaluation of prolonged murine monoclonal antibody 17-1A therapy in pancreatic carcinomaL M Weiner, E Harvey, K Padavic-Shaller, et al.
The American Journal of Gastroenterology|September 25, 2001
Long term survival after pancreatic resection for pancreatic adenocarcinomaN A Ahmad, J D Lewis, G G Ginsberg, et al.
Pageof 9